SHR-1918, a monoclonal antibody against angiopoietin-like 3, in healthy subjects: a randomized, double-blind, placebo-controlled, phase 1 study

被引：0
|
作者：
Xie, Z. [1 ]
Ye, L. [1 ]
Hu, W. [2 ]
Lv, C. [3 ]
Zhu, M. [3 ]
机构：
[1] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou, Peoples R China
[2] Anhui Med Univ, Hosp 2, Hefei, Peoples R China
[3] Jiangsu Hengrui Pharmaceut Co Ltd, Shanghai, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects
    U. Voderholzer
    D. Riemann
    M. Hornyak
    J. Backhaus
    B. Feige
    M. Berger
    F. Hohagen
    European Archives of Psychiatry and Clinical Neuroscience, 2001, 251 : 117 - 123
  • [22] A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects
    Voderholzer, U
    Riemann, D
    Hornyak, M
    Backhaus, J
    Feige, B
    Berger, M
    Hohagen, F
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2001, 251 (03) : 117 - 123
  • [23] Chlamydia antibody response in healthy volunteers immunized with nonchlamydial antigens:: A randomized, double-blind, placebo-controlled study
    Johnsen, S
    Andersen, PL
    Stanek, G
    Christiansen, G
    Birkelund, S
    Berthelsen, LM
    Ostergaard, L
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) : 586 - 591
  • [24] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    NEUROLOGY, 2009, 72 (09) : 806 - 812
  • [25] Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects
    Becker, Anna M.
    Holze, Friederike
    Grandinetti, Tanja
    Klaiber, Aaron
    Toedtli, Vanja E.
    Kolaczynska, Karolina E.
    Duthaler, Urs
    Varghese, Nimmy
    Eckert, Anne
    Grunblatt, Edna
    Liechti, Matthias E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (04) : 886 - 895
  • [26] REGENERATE: A Global Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of OCA for NASH
    Ratziu, Vlad
    Sanyal, Arun J.
    MacConell, Leigh
    Herrmann, Sibylle
    Shringarpure, Reshma
    Marmon, Tonya
    Shapiro, David
    Younossi, Zobair M.
    SWISS MEDICAL WEEKLY, 2016, 146 : 17S - 17S
  • [27] Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
    Hu, Bo
    Li, Gang
    Li, Xiaohong
    Wu, Shan
    Yu, Tingmin
    Li, Xiang
    Zhao, Hongru
    Jia, Zhihua
    Zhuang, Junpeng
    Yu, Shengyuan
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [28] Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
    Bo Hu
    Gang Li
    Xiaohong Li
    Shan Wu
    Tingmin Yu
    Xiang Li
    Hongru Zhao
    Zhihua Jia
    Junpeng Zhuang
    Shengyuan Yu
    The Journal of Headache and Pain, 2022, 23
  • [29] ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Tarantino, M.
    Bussel, J.
    Blanchette, V.
    Despotovic, J.
    Bennett, C.
    Raj, A.
    Williams, B.
    Beam, D.
    Morales, J.
    Rose, M.
    Carpenter, N.
    Eisen, M.
    HAEMATOLOGICA, 2016, 101 : 137 - 137
  • [30] Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study
    Earley, Willie
    Burgess, Maria Victoria
    Rekeda, Ludmyla
    Dickinson, Regan
    Szatmari, Balazs
    Nemeth, Gyorgy
    McIntyre, Roger S.
    Sachs, Gary S.
    Yatham, Lakshmi N.
    AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (06): : 439 - 448
12345